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A B S T R A C T   
The use of plasmonic metasurface for sensing has great potential on label-free detection of human tumor 
markers, which could benefit clinical examination. In this work, we adopt nanoimprint and plasma etching to 
optimize the nanofabrication for low-cost flexible plasmonic metasurface sensors with gold nanobump arrays, 
which enable facile surface bio-functionality, high sensitivity and simple optical measurement in the visible 
range. A high bulk refractive index sensitivity of 454.4 nm/RIU is achieved for the prototype plasmonic meta-
surface sensors at the wavelengths from 620 nm to 720 nm. The rapid quantitative tumor marker sensing of 
carcinoembryonic antigen in human serum samples from less than 10 ng/mL to more than 87 ng/mL is achieved, 
which demonstrates good agreement with the conventional chemiluminescence immunoassay system and suf-
ficiently covers the threshold tumor marker concentration of 20 ng/mL for early cancer prediction. Our method 
is capable of low-cost high-throughput manufacturing for flexible lightweight plasmonic metasurface sensors, 
which will facilitate wide applications on portable biomedical sensing devices for future point-of-care diagnosis 
and mobile healthcare.   
1. Introduction 
Plasmonic metasurfaces are the 2-dimensional versions of meta-
materials, which commonly consist of an array of unit metal nano-
structure elements with specifically designed geometry, size, and 
orientation (Cai et al., 2015; Chen et al., 2019; Costantini et al., 2015; 
L�opez-Mu~noz et al., 2017; Qin et al., 2016; Reshef et al., 2019; Wang and 
Zhan, 2016). In the past few years, the research of plasmonic metasur-
face has attracted significant attention due to the increasing application 
demand on optical lens, sensing, light trapping, integrated circuit, 
high-resolution imaging, chemical analysis and photo-thermal manip-
ulation (Bouchal et al., 2019; Hwang and Davis, 2016; Liang et al., 2017; 
Ndukaife et al., 2014; Tang et al., 2016; Xu et al., 2011; Zhu et al., 2011). 
Among these investigations, label-free biomolecular sensing based on 
plasmonic metasurfaces has demonstrated considerable achievements, 
which benefits from the nanoscale near-field enhancement with high 
sensitivity and non-destructive operation for high-throughput real-time 
detection (Cetin et al., 2015; Liu et al., 2018; Zhou et al., 2019). Driven 
by the intensive demands on fast, highly sensitive and cost-effective 
biosensing for point-of-care diagnosis and mobile healthcare (Zhang 
et al., 2015, 2018), many efforts have been made to improve the per-
formance of plasmonic sensors by using various nanostructured meta-
surfaces (Cai et al., 2019; Danilova et al., 2018; Tokel et al., 2014; Wang 
and Fan, 2016). 
Plasmonic metasurface biosensors typically need uniform periodic 
nanostructures with few defects, fine features, and large-area patterns 
via a low-cost and reproducible fabrication process. However, in order 
to maintain their high sensing performance, sophisticated nano-
fabrication methods are usually adopted, such as focused ion beam and 
electron beam lithography. Based on the serial operation, they usually 
involve a time-consuming and expensive patterning process on rigid 
substrates such as silicon, glass or fused silica (Feng et al., 2019; Jack-
man et al., 2017; Singh, 2016; �Spa�ckov�a et al., 2016). Conventional 
nanoimprint lithography might be an alternative way to reduce the 
fabrication cost, but the plasmonic nanostructures have been typically 
fabricated on costly rigid substrates (Jo et al., 2016). Up to date, the 
previous efforts still hinder the practical applications of plasmonic 
metasurfaces, particularly in lightweight, wearable and disposable bio-
sensors. In addition, the bio-compatibility and bio-functionalization of 
plasmonic metasurfaces are also very critical in practical sensing 
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applications. So far the potential use of low-cost, flexible, disposable 
plasmonic metasurfaces with biomedical functionalization for 
high-performance biosensors has yet to be realized. 
In this work, we investigate the low-cost flexible bio-functionalized 
plasmonic metasurfaces for high sensitive label-free detection of 
tumor marker in human serum samples. The plasmonic metasurfaces 
with periodic gold nanobumps are fabricated on a flexible lightweight 
polycarbonate substrate in a resist-free way, which is simply processed 
by nanoimprint, etching and metal evaporation in a very short time (see 
Table S1 in the Supplementary Material). Our approach reduces the 
material cost from $ 6 to $ 0.85 and the weight from 1.87 g to 0.42 g for 
a 2 inch wafer. The low-cost plasmonic metasurfaces optimized by ox-
ygen plasma etching on lightweight plastic substrates demonstrate the 
enhanced bulk sensitivity and quality factor. Furthermore, the nano-
bump metasurfaces show high capability for carcinoembryonic antigen 
(CEA) detection, which makes it potentially suitable for emerging flex-
ible plasmonic biosensing devices. 
2. Materials and methods 
2.1. Materials and characterization 
The polycarbonate slices used as the substrates are purchased from 
Obducat AB (Lund, Sweden). The self-assembly reagent 11-Mercaptoun-
decanoic acid (MUA) is from Cool Chemistry (Beijing, China). Phosphate 
buffer saline (PBS), 1-Ethyl-3-[3-dimethylaminopropyl] carbodiimide 
hydrochloride (EDC) and N-hydroxysuccinimide (NHS) are purchased 
from LvYin Reagent (Xiamen, China). Bovine serum albumin (BSA) is 
from Sangon Biotech (Shanghai, China). CEA and its antibody anti-CEA 
are from Siemens Healthcare Diagnostics (New York, USA). We use the 
atomic force microscope (AFM, SPA400) and scanning electron micro-
scope (SEM, Carl Zeiss SIGMA HD) to characterize the morphology of 
the plasmonic metasurfaces. The energy dispersive spectroscopy (EDS) 
combined with the SEM is used to obtain the high-speed elemental 
mapping on the plasmonic metasurfaces. 
2.2. Fabrication of plasmonic metasurfaces 
The fabrication work flow is shown from Fig. 1(a) to Fig. 1(c). The 
periodic nanocylinder arrays are imprinted on the polycarbonate sub-
strate using a 2-inch nickel mold with void nanocylinder arrays by 
thermal processing at a temperature range between 110 �C and 150 �C 
under a pressure of 40 bar. After that, the nanocylinders are changed to 
nanobumps by oxygen plasma under various etching time, and evapo-
rated by 5 nm chromium and 150 nm gold. 
2.3. Bio-functionalization of plasmonic metasurfaces 
In this process, the plasmonic metasurfaces are bio-functionalized by 
thiolate modification and covalent immobilization of anti-CEA, as 
shown from Fig. 1(d)–1(f). At the beginning, they are kept in the 1 mM 
MUA solution of ethanol for over 12 h, in which a self-assembled MUA 
monolayer is formed on their top surface. Then, they are cleaned by 
deionized water thoroughly and kept in a solution with 400 mM EDC 
and 100 mM NHS for half an hour in order to activate the MUA mono-
layer (Lee et al., 2015). After that, they are cleaned with deionized water 
again and incubated by 300 μL anti-CEA PBS solution (40 μg/mL) in a 
micro-chamber and maintained for 1 h, followed by BSA injection for 
blocking nonspecific adsorption (Niu et al., 2014). At last, the 
bio-functionalized metasurfaces are washed by deionized water and 
ready for use. 
2.4. Optical measurement and simulation 
A spectrometer with an integrated optical fiber probe (Avantes BV, 
Apeldoom, Netherlands) is used to measure the reflectance spectra of all 
Fig. 1. (a)~(c) Fabrication process of the plasmonic metasurface. (d)~(g) Schematic drawing of bio-functionalization and tumor marker detection.  
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plasmonic metasurface samples. The probe has 6 lighting fibers and 1 
reading fiber (200 μm core) with the measuring range from visible to 
near-infrared. In the measurements, the probe is perpendicularly on top 
of the samples with a distance of about 4 mm and the reflectance from a 
gold mirror is used as a spectral reference. For the biomolecule detec-
tion, the incubation micro-chambers are filled with deionized water. 
Optical simulation based on the finite element method is exploited to 
investigate the optical reflectance from the metasurface by normal 
incidence and the corresponding plasmonic effects. Infinite unit cells are 
adopted with Floquet periodic boundary conditions. The dispersive 
optical permittivity of gold is obtained from the literature (Johnson and 
Christy, 1972). Adaptive inhomogeneous tetrahedral meshing is used to 
discretize the simulation model (Zhu et al., 2016). The minimum edge 
length of the mesh element is set to 0.5 nm to ensure the simulation 
convergence and reproducibility. 
2.5. Specific binding and biosensing of CEA 
The detection of CEA is based on its specific binding on the anti-CEA, 
as shown in Fig. 1(g). In order to indicate the specificity of CEA for 
biomolecule binding, three kinds of phosphate buffer saline (PBS) so-
lutions of 30 ng/mL CEA, 63 ng/mL AFP, and 30 ng/mL CEA in com-
bination with 63 ng/mL AFP are detected by the bio-functionalized 
metasurfaces, respectively. Furthermore, the biosensing curve of CEA 
is confirmed by applying five CEA concentrations from 10 ng/mL to 
50 ng/mL. Each metasurface sample is kept inside one incubation micro- 
chamber with the 300 μL solution for 30 min and measured in the 
deionized water by the reflectance probe, as shown in Fig. 1(g). In the 
spectral measurements, three groups of solution are used for each con-
centration, which are further adopted for s.d. calculations. 
2.6. Diagnosis of CEA in human serums 
All the serum samples are collected from the First Affiliated Hospital 
of Xiamen University (Xiamen, China) with the consent from the in-
dividuals. These samples are tested in advance by the chem-
iluminescence immunoassay system (ADVIA Centaur XP, Siemens 
Healthineers). They are stored in the refrigerator at   20 �C and used for 
the test by the metasurfaces at room temperature after thawing. For each 
test, a serum sample of 300 μL is injected and incubated in a micro- 
chamber for 30 min. After that, the serum is extracted and the cham-
ber is filled with deionized water. The optical reflectance is measured 
and compared with that from the original bio-functionalized metasur-
face for the concentration calculation. 
3. Result and discussion 
3.1. Plasmonic effects and nanostructure optimization 
A simple process based on thermal nanoimprint, plasma etching and 
gold deposition are adopted to fabricate the flexible wafer-scale plas-
monic metasurfaces (Zhu et al., 2017), as shown in Fig. 2 (a) and (b). The 
nanofabrication is versatile and inexpensive for mass production. The 
metasurfaces have large areas of uniform periodic gold nanobumps, 
which facilitate the standardized manufacture for biosensing applica-
tions. These metasurfaces act as two-dimensional gratings with rectan-
gular reciprocal lattice vectors, which allows for the excitation of 
plasmonic resonance by coupling the incident light. The plasmonic 
resonance wavelengths under normal incidence could be estimated by 
the following equation (Ghaemi et al., 1998),  
λR ¼ P(ϵAuϵ)1/2[(ϵAuþϵ)(m2þn2)]  1/2                                                  (1) 
where P, integers (m, n), ϵAu and ϵ represent the periodicity of gold 
nanobumps, the grating orders of the corresponding reciprocal vectors, 
the permittivity of gold and the environmental permittivity at the 
resonance wavelength, respectively. Equation (1) only considers an 
ideal lattice of nanostructure with the fixed periodicity P for the esti-
mation of plasmonic resonance wavelength, but it neglects the 
morphology and size effects of the gold nanostructure (Molen et al., 
2004; Gordon et al., 2004). Some previous studies have implied that the 
morphology and size of the unit element should be well engineered, 
because they will influence the sensing performance significantly. 
In this study, the oxygen plasma etching on the nanostructured 
polycarbonate is an efficient method to optimize the plasmonic meta-
surface for high performance optical sensing. As shown from Fig. 2(c)–2 
(e), we can obtain various gold nanostructures by tuning the oxygen 
flow rate, radio-frequency power and etching time (Zhu et al., 2012). 
Fig. 2. (a) Photograph of the large-area flexible metasurface and (b) its corresponding SEM image. (c)~(e) SEM images for samples without etching, with 425s 
etching and with 575s etching, respectively. 
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The original gold nanocylinders in Fig. 2(c) can be etched into the gold 
nanobumps in Fig. 2(d), which demands appropriate optimization on 
nanofabrication. The over etching obtains gold nanodots as shown in 
Fig. 2(e), but it also brings about an increased roughness of the substrate 
background. In principle, a high quality factor and a small full wave at 
half maximum (FWHM) for plasmonic resonance are quite in demand for 
high performance refractive index sensing. The plasmonic resonance 
features significantly depend on the size and morphology of the meta-
surface, and this can be well engineered and optimized by oxygen 
plasma etching on the polycarbonate nanostructure. As shown in Fig. 3, 
the nanostructure fabricated without etching demonstrates a large 
FWHM and a low quality factor, despite it is in the air or in the water. 
The sample fabricated by over etching (e.g. 575s) indicates the reflection 
property in the air like a flat gold film, and shows two obvious resonance 
dips in the water, but the resonances have low quality factors and large 
FWHMs. For an optimized etching time of 425s, the metasurface shows 
the similar plasmonic resonance feature as the over etched one in the air, 
but it demonstrates a remarkable plasmonic resonance with a narrow 
FWHM around the wavelength of 650 nm, which is very beneficial for 
the refractive index sensing. The pronounced differences for the 425s 
etching between Fig. 3(a) and Fig. 3(b) can be explained as below. In the 
air, the low order plasmonic resonance is depressed and merged with the 
Fig. 3. Reflectance spectra for three kinds of plasmonic metasurfaces fabricated by no etching (0 s), optimal etching (425 s) and over etching (575 s) on poly-
carbonate nanostructures, respectively. (a) Measurement in the air. (b) Measurement in the water. 
Fig. 4. (a) Simulated reflectance of the plasmonic metasurface in the water, where the inset denotes the simulation model with the unit cell. (b) Electric field 
distributions at the resonance wavelength. (c) Reflectance spectra for using various solvents. (d) Resonance wavelength as a function of refractive index and etching 
time with different sensitivities. 
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high order one due to the intrinsic loss in gold below the wavelength of 
550 nm, whereas the low order plasmonic resonance in the water can be 
effectively isolated and shows promising resonance feature as a result of 
the morphology and size optimization. 
3.2. Optical simulation and bulk refractive index sensing 
We next reveal the physical insight for plasmonic enhancement ef-
fects on the optical sensing by simulation. As shown in Fig. 4(a), the 
simulated reflectance spectrum for the plasmonic metasurface in the 
water shows a distinct dip due to the plasmonic resonance in the visible 
range, whose property is consistent with the measured result. The slight 
simulation deviation from the measurement might be due to the use of 
an ideal geometry modeling. As observed in Fig. 4(b), the electric field at 
the resonance wavelength is significantly enhanced and localized sur-
rounding the top surface and the side of the gold nanobump. Therefore, 
the near-field enhancement in combination with the good uniformity of 
the nanostructure will dramatically increase the sensitivity, which sta-
tistically reflects the change of local environmental refractive index due 
to the biomolecular binding on the entire metasurface. 
Before the biomolecule detection, the bulk refractive index sensing 
performance is evaluated experimentally by immersing the plasmonic 
metasurface in deionized water, ethanol, isopropanol and glycol, 
respectively (Zheng et al., 2019). As observed in Fig. 4(c), the spectral 
dip of plasmonic resonance shifts to longer wavelengths due to the in-
crease of refractive index of the environmental liquid, which is consis-
tent with the estimation of Equation (1). The resonance wavelength as a 
function of environmental refractive index by varying the etching time is 
shown in Fig. 4(d). The measurement error bars are too small to be 
observed in the figure. Compared with other etching-time configura-
tions in the experiments, we find that the optimized 425s etching shows 
the highest sensitivity of 454.4 nm/RIU (S ¼ Δn/Δλ), which is 
competitive with many other plasmonic sensors using conventional 
complanate arrays (see Table S2 in the Supplementary Material). Thus, 
the larger bulk refractive index sensitivity implies higher sensing per-
formance for the next biomolecule detection. 
3.3. Bio-functionalization and biomolecule specific sensing 
With the aim of biomolecule detection, we use the scheme of 
immunoassay through the reflection type of visible light measurement. 
The self-assembled monolayer of MUA is applied on the metasurface as 
an intermediate material layer to immobilize anti-CEA by the way of 
covalent-bonding for the bio-functionalization of metasurface (Camilo 
et al., 2019; Liu et al., 2016). The immobilized anti-CEA will selectively 
capture the CEA from the tested sample for the sensing. By the EDS 
analysis comparison between Fig. 5(a) and Fig. 5(b), we find that the 
nitrogen elemental density (a representative element to indirectly 
denote the increase of the protein content) is obviously increased after 
the CEA is captured by the anti-CEA-functionalized metasurface. As 
observed in Fig. 5(c), compared to the spectrum of bare metasurface, the 
spectra for the metasurface with MUA and the metasurface with 
MUA/anti-CEA have the redshifts of 3.60 nm and 4.98 nm, respectively, 
which result from the increase of effective local refractive index induced 
by the change of surface biomolecule. When we use the metasurface 
bio-functionalized by anti-CEA for the detection of 10 ng/mL CEA, the 
plasmonic resonance dip has another red shift of 0.82 nm. The ultimate 
red shift is correlated with the concentration of CEA, which can be 
further investigated for CEA detection. 
The metasurface immobilized by anti-CEA is developed for the final 
CEA test of the human serum samples. Nevertheless, the human serum is 
a complicated mixture with diverse antibodies and antigens, which 
might interfere the detection result. In order to exclude the possible 
influences from external interference, we test three kinds of solutions as 
shown in Fig. 5(d). This figure indicates that there is no change of the 
resonance wavelength for the 63 ng/mL AFP solution, compared with 
that of the bio-functionalized metasurface. However, there is the same 
red shift of about 1.68 nm for both the 30 ng/mL CEA solution and the 
solution with 30 ng/mL CEA and 63 ng/mL AFP. Due to the biomolecule 
specificity, the metasurface functionalized by anti-CEA only selectively 
binds CEA from the solutions, and there is no specific binding of AFP 
biomolecules on the surface. These results well indicate the immuno-
logic specificity of the bio-functionalized metasurface for CEA detection. 
Fig. 5. Nitrogen elemental mapping by EDS 
(top view, collected by 3 min) for (a) the 
functionalized metasurface and (b) the met-
asurface immobilized by CEA, where the 
blue dots denote the density of nitrogen 
element. (c) Reflectance spectra for the bare 
metasurface, metasurface with MUA, meta-
surface with MUA/anti-CEA, and metasur-
face with MUA/anti-CEA/CEA, where 
t ¼ 425s. (d) Reflectance spectra for 
biomolecule specificity test, where t ¼ 475s. 
(For interpretation of the references to 
colour in this figure legend, the reader is 
referred to the Web version of this article.)   
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3.4. Tumor marker sensing and serum detection 
The sensing property in Fig. 6(a) is obtained from the measurement 
using five different concentrations of commercial CEA solutions from 
10 ng/mL to 50 ng/mL (Ameen et al., 2017). Each measurement has the 
same incubation time and the same solution volume in the detection 
chamber, and each error bar of measurement is based on s.d. calculation 
for three data points. Fig. 6(a) denotes the resonance wavelength shift as 
a function of the CEA concentration, which implies that the shift of 
spectral dip is increased proportionally to the CEA concentration. The 
correlation coefficient R of 0.995 illuminates a good linear relationship 
between the CEA concentration and resonance wavelength shift. The 
tumor marker detection of CEA in serum samples are performed by using 
the optimized plasmonic metasurfaces, as shown in Fig. 6(b). Compared 
with the results from the Siemens immunoassay system, the largest data 
deviation for the detected results by using the metasurfaces is less than 
4.8%, which demonstrates good consistency with clinical examination 
in the hospital. In addition, all the detections can be done simulta-
neously within 30 min. The CEA concentration of about 20 ng/mL is a 
critical threshold for diagnosis and prognosis of cancer, so the plasmonic 
metasurfaces have sufficiently covered the sensing range of an effective 
screening for cancer, as shown in Fig. 6(b). Our experimental results 
indicate the promising potential of the flexible metasurfaces for prac-
tical medical applications. 
4. Conclusion 
In summary, the plasmonic metasurface of gold nanobump array 
achieved by an optimized nanofabrication process provides many ad-
vantages for tumor maker detection in human serum. The all-gold 
sensing surface facilitates the process of antibody functionalization 
that requires the metasurface to be thiolated in advance. The optimized 
plasmonic metasurface allows the reflection-type measurement at 
normal incidence, and the light source as well as the photodetector are 
located on the same side, which consumedly simplifies the optical 
detection system. The sensing spectral region are established within the 
operating wavelengths of silicon photodiodes, which reduces the cost of 
analytical instrumentation significantly. The flexible lightweight plas-
monic metasurfaces based on low-cost manufacture and simple optical 
configuration demonstrate a promising potential for future 
portable medical devices/systems in point-of-care diagnosis and mobile 
healthcare. 
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